GGrantIndex
Sort

21,281 grants matching influenza

Macrophage differentiation and disease outcome in influenza infection

$555,603
Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2017 · AI

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

$555,535
Michel C Nussenzweig · Rockefeller University · U19 · FY2015 · AI

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

$555,526
Sara Lustigman · New York Blood Center · U01 · FY2019 · AI

Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens

$555,313
Pei Zhou · Duke University · R01 · FY2020 · AI

Generation of antigen-specific regulation T cells

$555,202
Harald Von Boehmer · Dana-Farber Cancer Inst · R37 · FY2006 · AI

Epidemiology and Etiology of Hospitalized Pneumonia in Children

$555,082
Krow Ampofo · University Of Utah · U18 · FY2010 · IP

Functional Implications of Tfh Cell Heterogeneity after Infection

$554,964
Troy D Randall · University Of Alabama At Birmingham · R01 · FY2024 · AI

Functional Implications of Tfh Cell Heterogeneity after Infection

$554,964
Andre Ballesteros-Tato · University Of Alabama At Birmingham · R01 · FY2023 · AI

Functional Implications of Tfh Cell Heterogeneity after Infection

$554,964
Andre Ballesteros-Tato · University Of Alabama At Birmingham · R01 · FY2022 · AI

Rational design and evaluation of novel mRNA vaccines against MERS-CoV

$554,964
Lanying Du · Georgia State University · R01 · FY2021 · AI

Functional Implications of Tfh Cell Heterogeneity after Infection

$554,964
Troy D Randall · University Of Alabama At Birmingham · R01 · FY2025 · AI

Impacts of Individual and Social Behavior on Influenza Dynamics and Control

$554,963
Alison P Galvani · Yale University · U01 · FY2010 · GM

Novel lung resident interstitial macrophage subset with distinct localization and polarization

$554,875
Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2020 · AI

Manipulating immunodominance in influenza HA

$554,789
Philip R Dormitzer · Boston Children'S Hospital · P01 · FY2011 · AI

Use of probiotics to modulate antimicrobial peptide signaling in the neonatal innate immune response to influenza virus

$554,786
Alison J Carey · Drexel University · R56 · FY2025 · AI

Task B12: Comprehensive Virology Panel

$554,675
Norman Kneteman · Utah State University · N01 · FY2013 · AI

Deep sequencing of pathogens to precisely define transmission networks using rare variants

$554,524
William Hanage · Harvard School Of Public Health · R01 · FY2021 · AI

Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses

$554,469
Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2013 · AI

Role of Microbiome in Neonatal Lung Maturation and Immune Susceptibility

$554,328
Lisa A Miller · University Of California At Davis · R01 · FY2020 · AI

Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41

$554,290
Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR

Harnessing Natural Killer T cells to counteract swine influenza

$554,278
John Driver · University Of Florida · R01 · FY2018 · HD

Novel Therapeutic Approach to Acute Lung Injury

$554,199
Sutip Navankasattusas · Navigen, Inc. · R44 · FY2010 · HL

FcRn-Targeted Mucosal Vaccination Against Influenza Infections

$554,124
Xiaoping Zhu · Univ Of Maryland, College Park · R01 · FY2019 · AI

University of Rochester Vaccine and Treatment Evaluation Unit(VTEU)- DMID-21-0004

$554,098
Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI

Pathogenesis of RSV disease in the Elderly

$553,944
University Of Rochester · U01 · FY2005 · AI